Jürgen Eckhardt

Director/Board Member at METAGENOMI THERAPEUTICS, INC.

Net worth: - $ as of 2026-02-27

59 year

81 connections

Health Technology

Health Services

Commercial Services

Profile

Jürgen Eckhardt is Director at eGenesis, Inc. since 2019; Director at Triumvira Immunologics, Inc. since 2020; Member Board of Directors at Joyn Bio LLC since 2017; Director at Khloris Biosciences, Inc. since 2018; Director at Dewpoint Therapeutics, Inc. since 2019; Director at Immunitas Therapeutics, Inc. since 2019; Director at Oerth Bio LLC since 2019; Director at Vesigen, Inc. since 2020; Independent Director at Metagenomi, Inc. since 2024; Board Member at Ada Health GmbH since 2021; Head of Leaps at Leaps by Bayer since 2019; and Head-Business Development & Licensing at Bayer AG since 2023.
Former roles include Chairman at Neoptics AG and Metagenomi Technologies LLC; Member Board of Directors at BlueRock Therapeutics Canada ULC from 2016 to 2021; Member Board of Directors at 9905553 Canada, Inc., Pairwise Plants Services, Inc., Casebia Therapeutics LLP, and Plant Response, Inc. from 2018 to 2019; Director at Century Therapeutics, Inc. from 2019 to 2021; Director at Triumvira Immunologics USA, Inc.; Board Member at Calypso Medical Technologies, Inc. from 2005 to 2011; Board Member at TargeGen, Inc. from 2005 to 2010; Associate Partner at McKinsey & Co., Inc.; Board Observer at Cameron Health, Inc. from 2008 to 2012; Board Member at Informed Data Systems, Inc.; Assoc Principal at The Global Life Science Ventures GmbH from 2002 to 2014; Board Member at Anteis SA from 2008 to 2013; Board Member at swiss smile Holding AG from 2006 to 2013; Head of Private Equity/Venture Capital at Bellevue Asset Management (Venture Capital) from 2004 to 2016; Board Member at Aleva Neurotherapeutics SA from 2011 to 2016; and Board Member at Pyxis Oncology, Inc. Education includes an MBA from INSEAD conferred in 1996 and a doctorate from the University of Basel conferred in 1992.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
METAGENOMI THERAPEUTICS, INC. -.--%	2025-04-13	0 ( -.--% )	- $	2026-02-27

Jürgen Eckhardt active positions

Companies	Position	Start
METAGENOMI THERAPEUTICS, INC.	Director/Board Member	2024-01-31
BAYER AG	Corporate Officer/Principal	2023-08-31
Immunitas Therapeutics, Inc. Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs	Director/Board Member	2019-09-30
Joyn Bio LLC Joyn Bio LLC Real Estate DevelopmentFinance Provides real estate services	Director/Board Member	2017-11-30
Oerth Bio LLC Oerth Bio LLC BiotechnologyHealth Technology Develops biotechnology products	Director/Board Member	2019-05-31
Ada Health GmbH Ada Health GmbH Internet Software/ServicesTechnology Services Operates as symptom assessment application	Director/Board Member	2021-04-30
Khloris Biosciences, Inc. Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company	Director/Board Member	2018-11-30
Leaps by Bayer Leaps by Bayer Investment ManagersFinance Leaps by Bayer invests in companies located in the United States and Germany. The firm targets companies operating in the fields of healthcare and agriculture sectors. It provides financing for early stage capital requirements.	Private Equity Investor	2019-02-28
Triumvira Immunologics, Inc. Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Director/Board Member	2020-03-31
░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░

All active positions of Jürgen Eckhardt

Former positions of Jürgen Eckhardt

Companies	Position	End
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░ ░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░

See the detail of Jürgen Eckhardt's experience

Training of Jürgen Eckhardt

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jürgen Eckhardt's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	34
Bayer AG Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services	Health Technology
Calypso Medical Technologies, Inc. Calypso Medical Technologies, Inc. Medical/Nursing ServicesHealth Services Provides radiation therapy and medical services	Health Services
TargeGen, Inc. TargeGen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures vascular biopharmaceutical products	Health Technology
McKinsey & Co., Inc. McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm	Commercial Services
Cameron Health, Inc. Cameron Health, Inc. Medical SpecialtiesHealth Technology Develops medical devices	Health Technology
INSEAD INSEAD Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Global Life Science Ventures GmbH The Global Life Science Ventures GmbH Investment ManagersFinance GLSV is an active, long-term manager which aims to create and build value exclusively in life science companies in the UK, Switzerland, German-speaking countries and the US. They invest in many areas of the life sciences including the cancer, immunology, vaccines, biopharmaceuticals, indication-specific genomics, genomics tools, diagnostics, medical devices, healthcare services and cardiovascular areas. The firm primarily invests in early-stage companies that operate in significant markets with considerable upside potential, as well as in later-stage companies, including buyouts, which meet their investment in their home markets, GLSV is the lead investor or an active co-investor, while outside of their home markets they only act as a knowledgeable co-investor.	Finance
University of Basel University of Basel Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Anteis SA Anteis SA Medical/Nursing ServicesHealth Services Modifies and functionalizes injectable hyaluronic acid for a range of medical applications	Health Services
swiss smile Holding AG swiss smile Holding AG Medical/Nursing ServicesHealth Services Operates as a holding company with interests in operates a chain of dental clinics	Health Services
Bellevue Asset Management (Venture Capital) Bellevue Asset Management (Venture Capital) Investment ManagersFinance Bellevue Asset Management (Venture Capital) is an active manager which invests primarily in private companies developing and marketing drugs and medical devices or providing healthcare services. The investment focus is on the US and Europe. The firm typically invests USD 7-15 million over an investee companies' lifetime, seeking to invest in companies with entrepreneurial individuals/teams, the ability to attain milestones in a timely manner, an advanced clinical pipeline, a proven technology base, good commercialization potential, growing markets, a medical need, significant competitive advantages, barriers to entry and a clear path to liquidity. It generally co-invests in syndicates with other venture capital firms, both leading the syndicate and acting as an active co-investor. It normally seeks representation on the boards of their portfolio companies, partnering with management to create value. The firm typically holds an investment for three to five years.	Finance
Aleva Neurotherapeutics SA Aleva Neurotherapeutics SA Electronic Equipment/InstrumentsElectronic Technology Develops next-generation implants for deep brain stimulation therapy	Electronic Technology
Neoptics AG Neoptics AG Electronic Equipment/InstrumentsElectronic Technology Provides early stage medical technology	Electronic Technology
Informed Data Systems, Inc. Informed Data Systems, Inc. Packaged SoftwareTechnology Services Develops AI health predictive platform	Technology Services
eGenesis, Inc. eGenesis, Inc. Medical/Nursing ServicesHealth Services Operates as a biotechnology company that provides organs and cells transplantation services	Health Services
Triumvira Immunologics, Inc. Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Health Technology
BlueRock Therapeutics Canada ULC BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Develops induced pluripotent stem cell therapies to cure the diseases	Health Technology
9905553 Canada, Inc. 9905553 Canada, Inc. Internet Software/ServicesTechnology Services Operates as a grain accounting and marketing platform for farmers and their advisors	Technology Services
Ada Health GmbH Ada Health GmbH Internet Software/ServicesTechnology Services Operates as symptom assessment application	Technology Services
Pairwise Plants Services Pairwise Plants Services Food: Major DiversifiedConsumer Non-Durables Engages in cultivation of crops	Consumer Non-Durables
Casebia Therapeutics LLP Casebia Therapeutics LLP Miscellaneous Commercial ServicesCommercial Services Provides physical, chemical and analytical testing services	Commercial Services
Joyn Bio LLC Joyn Bio LLC Real Estate DevelopmentFinance Provides real estate services	Finance
Khloris Biosciences, Inc. Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company	Commercial Services
Dewpoint Therapeutics, Inc. Dewpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biomolecular condensates biotechnology company	Health Technology
Leaps by Bayer Leaps by Bayer Investment ManagersFinance Leaps by Bayer invests in companies located in the United States and Germany. The firm targets companies operating in the fields of healthcare and agriculture sectors. It provides financing for early stage capital requirements.	Finance
Pyxis Oncology, Inc. Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics	Health Technology
Metagenomi Technologies LLC Metagenomi Technologies LLC BiotechnologyHealth Technology Develops genetic medicines using metagenomics-powered genome editing toolbox	Health Technology
Immunitas Therapeutics, Inc. Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs	Health Technology
Plant Response, Inc. Plant Response, Inc. Agricultural Commodities/MillingProcess Industries Develops soil health solutions	Process Industries
Oerth Bio LLC Oerth Bio LLC BiotechnologyHealth Technology Develops biotechnology products	Health Technology
Vesigen, Inc. Vesigen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company	Health Technology
Metagenomi, Inc. Metagenomi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a genetic medicines company that develops curative therapeutics for patients	Health Technology
Triumvira Immunologics USA, Inc. Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures novel T cell therapies for cancer	Commercial Services
Century Therapeutics, Inc. /Old/ Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company	Health Technology